EDGAR Filing Documents for 0001654954-20-012854

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001654954-20-012854

Filing Date

2020-11-24

Accepted

2020-11-23 17:55:21

Documents

Period of Report

2020-11-09

Document Format Files

Seq	Description	Document	Type	Size
1	PRIMARY DOCUMENT	form6-k_proxy.htm	6-K	20561
2	EXHIBIT 99.1	exh_991.htm	EX-99.1	33526
3	EXHIBIT 99.2	ex992.htm	EX-99.2	496269
4	EXHIBIT 99.3	ex993.htm	EX-99.3	8055
5	EXHIBIT 99.4	ex994.htm	EX-99.4	2443
6	EXHIBIT 99.5	ex995.htm	EX-99.5	13420
7	IMAGE	astlogo.jpg	GRAPHIC	3288
8	IMAGE	ex994000.jpg	GRAPHIC	67174
9	IMAGE	ex994001.jpg	GRAPHIC	137239
10	IMAGE	graph.jpg	GRAPHIC	41480
11	IMAGE	intellipharmaceutics_logo.jpg	GRAPHIC	7239
	Complete submission text file	0001654954-20-012854.txt		929156

Mailing Address 30 WORCESTER ROAD TORONTO A6 M9W 5X2

Business Address 30 WORCESTER ROAD TORONTO A6 M9W 5X2 416-798-3001

Intellipharmaceutics International Inc. (Filer) CIK: 0001474835 (see all company filings)